About Eledon Pharmaceuticals, Inc.
Targeting the CD40L pathway to develop potential therapies for organ and cell transplantation, autoimmune conditions.
Targeting the CD40L pathway to develop potential therapies for organ and cell transplantation, autoimmune conditions.